FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024343397> ?p ?o ?g. }

• W2024343397 endingPage "77" @default.
• W2024343397 startingPage "57" @default.
• W2024343397 abstract "The Bhas 42 cell transformation assay is a sensitive short-term system for predicting chemical carcinogenicity. Bhas 42 cells were established from BALB/c 3T3 cells by the transfection of v-Ha-ras gene and postulated to have acquired an initiated state in the two-stage carcinogenesis theory. The Bhas 42 cell transformation assay is capable of detecting both tumor-initiating and tumor-promoting activities of chemical carcinogens. The full assay protocol consists of two components, the initiation assay and the promotion assay, to detect the initiating activity and the promoting activity, respectively. An international study was carried out to validate this cell transformation assay in which six laboratories from three countries participated. Twelve coded chemicals were examined in total and each chemical was tested by three laboratories. In the initiation assay, concordant results were obtained by three laboratories for eight out of ten chemicals and in the promotion assay, concordant results were achieved for ten of twelve chemicals. The positive results were obtained in all three laboratories with the following chemicals: 2-acetylaminofluorene was positive in both initiation and promotion assays; dibenz[a,h]anthracene was positive in the initiation assay; sodium arsenite, lithocholic acid, cadmium chloride, mezerein and methapyrilene hydrochloride were positive in the promotion assay. o-Toluidin hydrochloride was positive in the both assays in two of the three laboratories. d-Mannitol, caffeine and l-ascorbic acid were negative in both assays in all the laboratories, and anthracene was negative in both assays in two of the three laboratories except one laboratory obtaining positive result in the promotion assay. Consequently, the Bhas 42 cell transformation assay correctly discriminated all six carcinogens and two tumor promoters from four non-carcinogens. Thus, the present study demonstrated that the Bhas 42 cell transformation assay is transferable and reproducible between laboratories and applicable to the prediction of chemical carcinogenicity. In addition, by comparison of the present results with intra-laboratory data previously published, within-laboratory reproducibility using the Bhas 42 cell transformation assay was also confirmed." @default.
• W2024343397 created "2016-06-24" @default.
• W2024343397 creator A5001481158 @default.
• W2024343397 creator A5003937757 @default.
• W2024343397 creator A5013853141 @default.
• W2024343397 creator A5017338958 @default.
• W2024343397 creator A5020137925 @default.
• W2024343397 creator A5020222112 @default.
• W2024343397 creator A5027175700 @default.
• W2024343397 creator A5032875054 @default.
• W2024343397 creator A5033291589 @default.
• W2024343397 creator A5044164306 @default.
• W2024343397 creator A5048087333 @default.
• W2024343397 creator A5054274900 @default.
• W2024343397 creator A5055331895 @default.
• W2024343397 creator A5057184445 @default.
• W2024343397 creator A5057944522 @default.
• W2024343397 creator A5061254561 @default.
• W2024343397 creator A5062657057 @default.
• W2024343397 creator A5066538333 @default.
• W2024343397 creator A5069969067 @default.
• W2024343397 creator A5073734748 @default.
• W2024343397 creator A5075189337 @default.
• W2024343397 creator A5078405205 @default.
• W2024343397 date "2011-10-01" @default.
• W2024343397 modified "2023-10-16" @default.
• W2024343397 title "An international validation study of a Bhas 42 cell transformation assay for the prediction of chemical carcinogenicity" @default.
• W2024343397 cites W1713048017 @default.
• W2024343397 cites W1967997972 @default.
• W2024343397 cites W1996531562 @default.
• W2024343397 cites W1998852023 @default.
• W2024343397 cites W2006453075 @default.
• W2024343397 cites W2007823508 @default.
• W2024343397 cites W2009418351 @default.
• W2024343397 cites W2026336642 @default.
• W2024343397 cites W2041419161 @default.
• W2024343397 cites W2052028397 @default.
• W2024343397 cites W2066585653 @default.
• W2024343397 cites W2076985013 @default.
• W2024343397 cites W2111108010 @default.
• W2024343397 doi "https://doi.org/10.1016/j.mrgentox.2011.07.006" @default.
• W2024343397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21801851" @default.
• W2024343397 hasPublicationYear "2011" @default.
• W2024343397 type Work @default.
• W2024343397 sameAs 2024343397 @default.
• W2024343397 citedByCount "32" @default.
• W2024343397 countsByYear W20243433972012 @default.
• W2024343397 countsByYear W20243433972013 @default.
• W2024343397 countsByYear W20243433972014 @default.
• W2024343397 countsByYear W20243433972015 @default.
• W2024343397 countsByYear W20243433972016 @default.
• W2024343397 countsByYear W20243433972017 @default.
• W2024343397 countsByYear W20243433972019 @default.
• W2024343397 countsByYear W20243433972020 @default.
• W2024343397 countsByYear W20243433972021 @default.
• W2024343397 countsByYear W20243433972022 @default.
• W2024343397 countsByYear W20243433972023 @default.
• W2024343397 crossrefType "journal-article" @default.
• W2024343397 hasAuthorship W2024343397A5001481158 @default.
• W2024343397 hasAuthorship W2024343397A5003937757 @default.
• W2024343397 hasAuthorship W2024343397A5013853141 @default.
• W2024343397 hasAuthorship W2024343397A5017338958 @default.
• W2024343397 hasAuthorship W2024343397A5020137925 @default.
• W2024343397 hasAuthorship W2024343397A5020222112 @default.
• W2024343397 hasAuthorship W2024343397A5027175700 @default.
• W2024343397 hasAuthorship W2024343397A5032875054 @default.
• W2024343397 hasAuthorship W2024343397A5033291589 @default.
• W2024343397 hasAuthorship W2024343397A5044164306 @default.
• W2024343397 hasAuthorship W2024343397A5048087333 @default.
• W2024343397 hasAuthorship W2024343397A5054274900 @default.
• W2024343397 hasAuthorship W2024343397A5055331895 @default.
• W2024343397 hasAuthorship W2024343397A5057184445 @default.
• W2024343397 hasAuthorship W2024343397A5057944522 @default.
• W2024343397 hasAuthorship W2024343397A5061254561 @default.
• W2024343397 hasAuthorship W2024343397A5062657057 @default.
• W2024343397 hasAuthorship W2024343397A5066538333 @default.
• W2024343397 hasAuthorship W2024343397A5069969067 @default.
• W2024343397 hasAuthorship W2024343397A5073734748 @default.
• W2024343397 hasAuthorship W2024343397A5075189337 @default.
• W2024343397 hasAuthorship W2024343397A5078405205 @default.
• W2024343397 hasConcept C104317684 @default.
• W2024343397 hasConcept C114246631 @default.
• W2024343397 hasConcept C1491633281 @default.
• W2024343397 hasConcept C153911025 @default.
• W2024343397 hasConcept C185592680 @default.
• W2024343397 hasConcept C204241405 @default.
• W2024343397 hasConcept C502942594 @default.
• W2024343397 hasConcept C55493867 @default.
• W2024343397 hasConcept C86803240 @default.
• W2024343397 hasConceptScore W2024343397C104317684 @default.
• W2024343397 hasConceptScore W2024343397C114246631 @default.
• W2024343397 hasConceptScore W2024343397C1491633281 @default.
• W2024343397 hasConceptScore W2024343397C153911025 @default.
• W2024343397 hasConceptScore W2024343397C185592680 @default.
• W2024343397 hasConceptScore W2024343397C204241405 @default.
• W2024343397 hasConceptScore W2024343397C502942594 @default.
• W2024343397 hasConceptScore W2024343397C55493867 @default.
• W2024343397 hasConceptScore W2024343397C86803240 @default.

• next